Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 4
1994 3
1995 7
1996 5
1997 8
1998 6
1999 2
2000 7
2001 5
2002 2
2003 1
2004 5
2005 4
2006 6
2007 3
2008 4
2009 7
2010 6
2011 4
2012 5
2013 6
2014 4
2015 9
2016 18
2017 19
2018 15
2019 8
2020 7
2021 5
2022 3
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. Among authors: hebbar m. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Recent advances in epilepsy genomics and genetic testing.
Hebbar M, Mefford HC. Hebbar M, et al. F1000Res. 2020 Mar 12;9:F1000 Faculty Rev-185. doi: 10.12688/f1000research.21366.1. eCollection 2020. F1000Res. 2020. PMID: 32201576 Free PMC article. Review.
Expanding the genotype-phenotype spectrum in SCN8A-related disorders.
Hebbar M, Al-Taweel N, Gill I, Boelman C, Dean RA, Goodchild SJ, Mezeyova J, Shuart NG, Johnson JP, Lee J, Michoulas A, Huh LL, Armstrong L, Connolly MB, Demos MK. Hebbar M, et al. Res Sq [Preprint]. 2023 Aug 8:rs.3.rs-3221902. doi: 10.21203/rs.3.rs-3221902/v1. Res Sq. 2023. PMID: 37609289 Free PMC article. Updated. Preprint.
Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma.
Curea FG, Hebbar M, Ilie SM, Bacinschi XE, Trifanescu OG, Botnariuc I, Anghel RM. Curea FG, et al. Among authors: hebbar m. Cancer Biother Radiopharm. 2017 Dec;32(10):351-363. doi: 10.1089/cbr.2017.2249. Cancer Biother Radiopharm. 2017. PMID: 29265917 Review.
[Immunotherapy of malignant melanoma. New prospects].
Hebbar M, Vanlemmens L, Lecomte S, Bonneterre J. Hebbar M, et al. Rev Med Interne. 1995;16(4):260-70. doi: 10.1016/0248-8663(96)80705-3. Rev Med Interne. 1995. PMID: 7746965 Review. French.
[Systemic sclerosis and pregnancy].
Launay D, Hebbar M, Valat AS, Ducloy AS, Hachulla E, Hatron PY, Ouk T, Devulder B. Launay D, et al. Among authors: hebbar m. Rev Med Interne. 2002 Jul;23(7):607-21. doi: 10.1016/s0248-8663(02)00622-7. Rev Med Interne. 2002. PMID: 12162216 Review. French.
Expanding the genotype-phenotype spectrum in SCN8A-related disorders.
Hebbar M, Al-Taweel N, Gill I, Boelman C, Dean RA, Goodchild SJ, Mezeyova J, Shuart NG, Johnson JP Jr, Lee J, Michoulas A, Huh LL, Armstrong L, Connolly MB, Demos MK. Hebbar M, et al. BMC Neurol. 2024 Jan 17;24(1):31. doi: 10.1186/s12883-023-03478-y. BMC Neurol. 2024. PMID: 38233770 Free PMC article.
176 results